Research Snappy
  • Market Research Forum
  • Investment Research
  • Consumer Research
  • More
    • Advertising Research
    • Healthcare Research
    • Data Analysis
    • Top Companies
    • Latest News
No Result
View All Result
Research Snappy
No Result
View All Result

Aston Martin’s Lifeline Buys Carmaker Time as SUV Hits Road

researchsnappy by researchsnappy
February 1, 2020
in Consumer Research
0
Colombian Stock Exchange Launches Crowd Funding Platform for Start-Ups
399
SHARES
2.3k
VIEWS
Share on FacebookShare on Twitter

LONDON — Canadian billionaire Lawrence Stroll and investors have rescued Aston Martin with a 500 million pound cash injection that analysts say will help stabilise the British carmaker whose first sport utility vehicle (SUV) is set to hit the road.

Stroll agreed to buy up to 20% of the 107-year-old company and will become executive chairman of James Bond’s automaker of choice, which has gone bankrupt seven times in its chequered history.

A consortium led by Stroll will invest 182 million pounds, whilst major existing shareholders – primarily Italian and Kuwaiti private equity groups – will be part of a rights issue to raise 318 million pounds.

“It likely gives them enough liquidity to tide them over for a couple of years,” said Charles Coldicott, Redburn equity research analyst.

Outgoing chairwoman Penny Hughes, who will be replaced by Stroll, spelt out the degree of trouble the firm has been in after core sales fell last year.

“The difficult trading performance in 2019 resulted in severe pressure on liquidity which has left the company with no alternative but to seek substantial additional equity financing,” she said.

“Without this the balance sheet is not robust enough to support the operations of the group.”

Now Aston will need to turn the financial lifeline into part of a sustainable plan as it delays investment in electric vehicles and cuts its operating costs.

A key future milestone includes around 1 billion pounds worth of debt due to mature in 2022.

The company also suffers from lower gross margins than rival Ferrari, according to analysts at Jefferies, who have said scaling up is just as important as extra capital.

Key to the company’s success is its first foray into the lucrative SUV market, a late entrant compared to many rivals such as Volkswagen-owned Bentley and BMW’s Rolls-Royce.

Aston has built a new factory in Wales to make the model, known as the DBX, which it hopes will attract more women to the brand and some buyers to purchase both it and a vehicle from its traditional line-up.

With the DBX model not due to roll off the production line until the second quarter of this year, the firm has taken the cost with only some of the benefit so far.

Based in central England, Aston said earlier this month that it already had around 1,800 orders for the car which will retail for 158,000 pounds in Britain, a “materially better” rate than for any previous models.

“When we were looking at the amount of money needed, we were thinking about deleveraging, creating the liquidity buffer that was missing and also be able to continue investing in some longer-term critical products including the mid-engine platform,” said Philippe Houchois, equity analyst at Jefferies.

“All that works as long as DBX is successful so they have to deliver that,” he said.

(Graphic: Aston Martin’s market value has plunged – https://fingfx.thomsonreuters.com/gfx/mkt/13/1651/1626/aston.png)

(Reporting by Costas Pitas; Editing by Josephine Mason)

Previous Post

CvCapital Advises Skybound Entertainment on Its New Funding Round By Com2uS, C Ventures and Third Wave Digital

Next Post

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Stock Rating Reaffirmed by B. Riley

Next Post
Arrowhead Pharmaceuticals (NASDAQ:ARWR) Stock Rating Reaffirmed by S&P Equity Research

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Stock Rating Reaffirmed by B. Riley

Research Snappy

Category

  • Advertising Research
  • Consumer Research
  • Data Analysis
  • Healthcare Research
  • Investment Research
  • News

Pa. Republicans reconsider Pitt funding over fetal tissue research, college voucher program

Arthur Pharma Closes Series A Financing Round

YouTube and the Achilles Tendon: An Analysis of Internet Information Reliability and Content Quality

  • Privacy Policy
  • Terms of Use
  • Antispam
  • DMCA
  • Contact Us

© 2022 researchsnappy.com

No Result
View All Result
  • Market Research Forum
  • Investment Research
  • Consumer Research
  • More
    • Advertising Research
    • Healthcare Research
    • Data Analysis
    • Top Companies
    • Latest News

© 2022 researchsnappy.com